MustGrow Biologics Corp (CSE: MGRO) this morning announced test results for use of its patented mustard derived bio-pesticide on clubroot spores, for which laboratory testing confirmed 100% control of the spores within a 24 hour period.
The news is significant in that it provides a potential solution to the clubroot disease that as of yet has no economical control measure available to eradicate it. Clubroot is a soil-borne disease caused by a fungus like protist that causes swellings or galls to form on the roots of canola plants, which results in premature death of the plant. Some infected fields have lead to 100% crop loss, which can be a devastating event for farmers.
MustGrow’s product has confirmed 100% control of clubroot spores after a 24-hour period via an independent third party laboratory with its TerraMG product. The application rate used for testing was low enough that it has the potential to be an economical solution for canola farmers.
The laboratory test was an initial proof of concept conducted at laboratory scale. Following the success of the testing, MustGrow will now conduct trials in a greenhouse setting, and upon successful results, in a larger field study.
The patented mustard derived bio-pesticide developed by MustGrow has been confirmed to 100% control a number of soil-borne disease and pathogens that include fusarium, botrytis, verticillium, nematodes and more. Additional work to be conducted by the firm will also confirm if it is just as effective against clubroot disease.
MustGrow Biologics last traded at $0.28 on the CSE.
FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.